77 related articles for article (PubMed ID: 16303607)
1. Effects of BM-573, a thromboxane A2 modulator on systemic hemodynamics perturbations induced by U-46619 in the pig.
Tchana-Sato V; Dogné JM; Lambermont B; Ghuysen A; Magis D; Morimont P; Hanson J; D'Orio V; Limet R; Kolh P
Prostaglandins Other Lipid Mediat; 2005 Dec; 78(1-4):82-95. PubMed ID: 16303607
[TBL] [Abstract][Full Text] [Related]
2. Effect of BM-573 [N-terbutyl-N'-[2-(4'-methylphenylamino)-5-nitro-benzenesulfonyl]urea], a dual thromboxane synthase inhibitor and thromboxane receptor antagonist, in a porcine model of acute pulmonary embolism.
Ghuysen A; Lambermont B; Dogné JM; Kolh P; Tchana-Sato V; Morimont P; Magis D; Hanson J; Segers P; D'Orio V
J Pharmacol Exp Ther; 2004 Sep; 310(3):964-72. PubMed ID: 15121765
[TBL] [Abstract][Full Text] [Related]
3. Effects of U-46619 on pulmonary hemodynamics before and after administration of BM-573, a novel thromboxane A2 inhibitor.
Lambermont B; Kolh P; Dogné JM; Ghuysen A; Tchana-Sato V; Morimont P; Benoit P; Gérard P; Masereel B; Limet R; D'Orio V
Arch Physiol Biochem; 2003 Jul; 111(3):217-23. PubMed ID: 14972743
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo pharmacological characterization of BM-613 [N-n-pentyl-N'-[2-(4'-methylphenylamino)-5-nitrobenzenesulfonyl]urea], a novel dual thromboxane synthase inhibitor and thromboxane receptor antagonist.
Hanson J; Rolin S; Reynaud D; Qiao N; Kelley LP; Reid HM; Valentin F; Tippins J; Kinsella BT; Masereel B; Pace-Asciak C; Pirotte B; Dogné JM
J Pharmacol Exp Ther; 2005 Apr; 313(1):293-301. PubMed ID: 15626721
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological characterization of N-tert-butyl-N'-[2-(4'-methylphenylamino)-5-nitrobenzenesulfonyl]urea (BM-573), a novel thromboxane A2 receptor antagonist and thromboxane synthase inhibitor in a rat model of arterial thrombosis and its effects on bleeding time.
Dogné JM; Hanson J; de Leval X; Kolh P; Tchana-Sato V; de Leval L; Rolin S; Ghuysen A; Segers P; Lambermont B; Masereel B; Pirotte B
J Pharmacol Exp Ther; 2004 May; 309(2):498-505. PubMed ID: 14742735
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of BM-573, a novel TXA2 synthase inhibitor and receptor antagonist, in a porcine model of myocardial ischemia-reperfusion.
Kolh P; Rolin S; Tchana-Sato V; Pétein M; Ghuysen A; Lambermont B; Hanson J; Magis D; Segers P; Masereel B; D'Orio V; Dogne JM
Prostaglandins Other Lipid Mediat; 2006 Mar; 79(1-2):53-73. PubMed ID: 16516810
[TBL] [Abstract][Full Text] [Related]
7. Protamine-heparin-induced pulmonary hypertension in pigs: effects of treatment with a thromboxane receptor antagonist on hemodynamics and coagulation.
Nuttall GA; Murray MJ; Bowie EJ
Anesthesiology; 1991 Jan; 74(1):138-45. PubMed ID: 1824742
[TBL] [Abstract][Full Text] [Related]
8. Effects of BM-573, a novel thromboxane A2 inhibitor, on pulmonary hemodynamics in endotoxic shock.
Lambermont B; Ghuysen A; Dogné JM; Kolh P; Tchana-Sato V; Morimont P; Benoit P; Gérard P; Masereel B; D'Orio V
Arch Physiol Biochem; 2003 Jul; 111(3):224-31. PubMed ID: 14972744
[TBL] [Abstract][Full Text] [Related]
9. Antiplatelet activity of carnosol is mediated by the inhibition of TXA2 receptor and cytosolic calcium mobilization.
Lee JJ; Jin YR; Lim Y; Hong JT; Kim TJ; Chung JH; Yun YP
Vascul Pharmacol; 2006 Sep; 45(3):148-53. PubMed ID: 16916624
[TBL] [Abstract][Full Text] [Related]
10. Involvement of brain thromboxane A in hypotension induced by haemorrhage in rats.
Yalcin M; Cavun S; Yilmaz MS; Cengiz F; Savci V
Clin Exp Pharmacol Physiol; 2005 Nov; 32(11):960-7. PubMed ID: 16405453
[TBL] [Abstract][Full Text] [Related]
11. BM-520, an original TXA2 modulator, inhibits the action of thromboxane A2 and 8-iso-prostaglandin F2alphain vitro and in vivo on human and rodent platelets, and aortic vascular smooth muscles from rodents.
Rolin S; Hanson J; Vastersaegher C; Cherdon C; Pratico D; Masereel B; Dogne JM
Prostaglandins Other Lipid Mediat; 2007 Aug; 84(1-2):14-23. PubMed ID: 17643884
[TBL] [Abstract][Full Text] [Related]
12. Pharmacology of the thromboxane receptor antagonist and thromboxane synthase inhibitor BM-531.
Dogné JM; Rolin S; de Leval X; Benoit P; Neven P; Delarge J; Kolh P; Damas J; David JL; Masereel B
Cardiovasc Drug Rev; 2001; 19(2):87-96. PubMed ID: 11484064
[TBL] [Abstract][Full Text] [Related]
13. Coagulation defects and altered hemodynamic responses in mice lacking receptors for thromboxane A2.
Thomas DW; Mannon RB; Mannon PJ; Latour A; Oliver JA; Hoffman M; Smithies O; Koller BH; Coffman TM
J Clin Invest; 1998 Dec; 102(11):1994-2001. PubMed ID: 9835625
[TBL] [Abstract][Full Text] [Related]
14. Thromboxane A2 receptor antagonism in man and rat by a sulphonylcyanoguanidine (BM-144) and a sulphonylurea (BM-500).
Masereel B; Damas J; Fontaine J; Lembege M; Lacan F; Nuhrich A; Delarge J; Pochet L; Dogne JM
J Pharm Pharmacol; 1999 Jun; 51(6):695-701. PubMed ID: 10454046
[TBL] [Abstract][Full Text] [Related]
15. A novel thromboxane receptor antagonist and synthase inhibitor, BM-573, reduces development and progression of atherosclerosis in LDL receptor deficient mice.
Cyrus T; Yao Y; Ding T; Dogné JM; Praticò D
Eur J Pharmacol; 2007 Apr; 561(1-3):105-11. PubMed ID: 17306791
[TBL] [Abstract][Full Text] [Related]
16. BM-573, a dual thromboxane synthase inhibitor and thromboxane receptor antagonist, prevents pig myocardial infarction induced by coronary thrombosis.
Rolin S; Petein M; Tchana-Sato V; Dogne JM; Benoit P; Lambermont B; Ghuysen A; Kolh P; Masereel B
J Pharmacol Exp Ther; 2003 Jul; 306(1):59-65. PubMed ID: 12721335
[TBL] [Abstract][Full Text] [Related]
17. Effect of a novel thromboxane A2 inhibitor on right ventricular-arterial coupling in endotoxic shock.
Lambermont B; Kolh P; Ghuysen A; Segers P; Dogné JM; Tchana-Sato V; Morimont P; Benoit P; Gérard P; Masereel B; D'Orio V
Shock; 2004 Jan; 21(1):45-51. PubMed ID: 14676683
[TBL] [Abstract][Full Text] [Related]
18. Different mechanisms between thromboxane A2- and leukotriene D4-induced nasal blockage in guinea pigs.
Tanaka Y; Mizutani N; Fujii M; Nabe T; Kohno S
Prostaglandins Other Lipid Mediat; 2006 Sep; 80(3-4):144-54. PubMed ID: 16939879
[TBL] [Abstract][Full Text] [Related]
19. Platelet antiaggregating activity of ginsenosides isolated from processed ginseng.
Lee JG; Lee YY; Kim SY; Pyo JS; Yun-Choi HS; Park JH
Pharmazie; 2009 Sep; 64(9):602-4. PubMed ID: 19827304
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological evaluation of the novel thromboxane modulator BM-567 (I/II). Effects of BM-567 on platelet function.
Dogné JM; de Leval X; Kolh P; Sanna V; Rolin S; Michaux C; Mauer M; David JL; Masereel B; Pirotte B
Prostaglandins Leukot Essent Fatty Acids; 2003 Jan; 68(1):49-54. PubMed ID: 12538090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]